Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126291861 | 12629186 | 1 | I | 20100112 | 20100120 | 20160808 | 20160808 | EXP | GB-ASTELLAS-2010000274 | ASTELLAS | 61.00 | YR | M | Y | 0.00000 | 20160808 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126291861 | 12629186 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | UNK UNK, ONCE DAILY | 0 | FORMULATION UNKNOWN | QD | ||||||||
| 126291861 | 12629186 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | 0 | FORMULATION UNKNOWN | |||||||||||
| 126291861 | 12629186 | 3 | C | FELODIPINE. | FELODIPINE | 1 | Oral | U | 0 | 5 | MG | FORMULATION UNKNOWN | |||||||
| 126291861 | 12629186 | 4 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | U | 0 | 20 | MG | FORMULATION UNKNOWN | |||||||
| 126291861 | 12629186 | 5 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | Oral | U | 0 | 2.5 | MG | FORMULATION UNKNOWN | |||||||
| 126291861 | 12629186 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 360 | MG | U | 0 | 4 | MG | FORMULATION UNKNOWN | BID | ||||
| 126291861 | 12629186 | 7 | C | PHENYTOIN. | PHENYTOIN | 1 | Oral | 150/200 MG AT AM/PM ( TWICE DAILY) | U | 0 | FORMULATION UNKNOWN | BID | |||||||
| 126291861 | 12629186 | 8 | C | RANITIDINE. | RANITIDINE | 1 | Oral | U | 0 | 30 | MG | FORMULATION UNKNOWN | |||||||
| 126291861 | 12629186 | 9 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | U | 0 | 150 | MG | FORMULATION UNKNOWN | |||||||
| 126291861 | 12629186 | 10 | C | ASACOL | MESALAMINE | 1 | Oral | 1299600 | MG | U | 0 | 400 | MG | FORMULATION UNKNOWN | TID | ||||
| 126291861 | 12629186 | 11 | C | ORAMORPH | MORPHINE SULFATE | 1 | Oral | UNK UNK, PRN (1 IN 1 AS NEEDED) | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126291861 | 12629186 | 1 | Non-small cell lung cancer |
| 126291861 | 12629186 | 2 | Metastases to central nervous system |
| 126291861 | 12629186 | 3 | Hypertension |
| 126291861 | 12629186 | 4 | Hypertension |
| 126291861 | 12629186 | 5 | Hypertension |
| 126291861 | 12629186 | 6 | Metastases to central nervous system |
| 126291861 | 12629186 | 7 | Seizure |
| 126291861 | 12629186 | 8 | Product used for unknown indication |
| 126291861 | 12629186 | 9 | Product used for unknown indication |
| 126291861 | 12629186 | 10 | Colitis ulcerative |
| 126291861 | 12629186 | 11 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126291861 | 12629186 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126291861 | 12629186 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126291861 | 12629186 | 1 | 20091202 | 20100112 | 0 | |
| 126291861 | 12629186 | 3 | 20041005 | 20100112 | 0 | |
| 126291861 | 12629186 | 4 | 20030227 | 20100112 | 0 | |
| 126291861 | 12629186 | 5 | 20060927 | 20100112 | 0 | |
| 126291861 | 12629186 | 6 | 20091129 | 20100112 | 0 | |
| 126291861 | 12629186 | 7 | 20091129 | 20100112 | 0 | |
| 126291861 | 12629186 | 8 | 20091202 | 20100112 | 0 | |
| 126291861 | 12629186 | 9 | 20090116 | 20100112 | 0 | |
| 126291861 | 12629186 | 10 | 20070126 | 20100112 | 0 | |
| 126291861 | 12629186 | 11 | 20100111 | 20100112 | 0 |